Drugs / A+C+hib Conjugate Vaccine
last change Nov 2012 re-read 2 minutes ago

A+C+hib Conjugate Vaccine

Vaccine

Developed for
influenza · meningitis
Investigated by
Jiangsu Province Centers for Disease Control and Prevention · Royal (Wuxi) Biological Co., LTD

Trials 1 · a red edge is where a trial was stopped

2012201320142015201620172018201920202021202220232024202520262027
PhaseRegistry idDatesIndicationSponsorStatusOutcome
Phase 3 NCT01580033 Apr → Sep 2012 influenza, meningitis Jiangsu Province Centers for Disease Control and Prevention Completed No outcome recorded

Evidence & citations 3 cited values

Every value below carries the sentence it was read from. 1 source stands behind the page.

FieldValueCited text
Known as A+C+hib Conjugate Vaccine ClinicalTrials.gov intervention name — accepted as the source's own label NCT01580033
Modality Vaccine “group A, C polysaccharide meningococcal and type b haemophilus influenzal conjugate vaccineNCT01580033
Route Intramuscular “will be administered on one arm, intramuscularly, per 0.5ml dose” NCT01580033